VasQ is a breakthrough, nitinol-based external vascular support device implanted around the artery and vein when surgically creating an arteriovenous fistula.
Trial will evaluate the safety and efficacy of its investigational pulsed field and radiofrequency ablation system for treating paroxysmal atrial fibrillation.
Kairos computes biometrics such as active and resting heart rate, HRV, beat-to-beat intervals, and respiratory rate as well as sleep-related parameters.